In HCC, cancer-associated fibroblasts (CAF) produce CCL5 that, upon binding to tumor cells, activates signals that interfere with the ubiquitination and degradation by the proteasome of hypoxia-inducible factor 1 alpha (HIF1α). This evidence concerns the gene HIF1A and neoplasm.